Descripción de la empresa
Brighthouse Financial, Inc. operates within the financial services sector, specifically focusing on the insurance-life industry, where it provides annuity and life insurance products to individuals across the United States. The company's operational structure is divided into three distinct segments: Annuities, Life, and Run-off, with the Annuities segment specifically offering variable, fixed, index-linked, and income annuities designed to meet the wealth accumulation and protection needs of contract holders. In terms of scale, the company employs approximately 1,400 individuals to support its operations, although specific market capitalization data is currently unavailable in the provided records. The absence of a listed market cap figure, combined with an annual revenue of $6.95 billion, suggests that valuation metrics may be driven by asset-heavy structures common in the insurance industry rather than traditional equity market capitalization, requiring analysts to rely on alternative valuation frameworks such as price-to-book ratios to assess the entity's true market position.
Salud financiera
The company reported a trailing twelve-month revenue of $6.95 billion, generating a net income of $331.00 million, while EBITDA data is not available for this specific reporting period. The significant gap between the $6.95 billion in revenue and the $331.00 million in net income reveals a cost structure where operating expenses and claims adjustments consume a substantial portion of top-line revenue, resulting in a profit margin of 6.2%. Regarding cash flow dynamics, the company recorded a free cash flow of $-607,374,976, which indicates a net outflow of capital that is typical for insurers investing heavily in reserves and liabilities rather than generating immediate cash for distribution. The balance sheet shows a cash position of $7.39 billion against total debt of $9.94 billion, resulting in a debt-to-equity ratio of 145.50, which characterizes a highly leveraged balance sheet where liabilities significantly exceed equity. Despite the high leverage, the current ratio stands at 0.68, indicating that current assets are insufficient to cover current liabilities without relying on future cash inflows or asset liquidation. Return on equity is measured at 7.4%, while return on assets is a modest 0.2%, suggesting that while shareholders face significant dilution from the high debt load, the management team must generate substantial revenue to overcome the cost of capital and maintain these return metrics.
Evaluación de valoración
The trailing twelve-month P/E ratio is recorded at 1.05, while the forward P/E ratio is not available; this disparity implies that analysts cannot currently project an earnings trajectory that would support a higher multiple, potentially reflecting the volatility in earnings growth. The price-to-book ratio is listed at 0.11, indicating that the market values the company's equity at a fraction of its book value, which often occurs when insurers hold large investment portfolios that are not fully reflected in the book value or when the business is in a run-off phase. Alternative valuation metrics such as price-to-sales and EV/EBITDA are both not available (N/A), suggesting that traditional growth-oriented valuation models are less applicable to this specific financial entity compared to those used for technology or consumer discretionary sectors. Over the past year, the stock has traded between a 52-week low of $11.51 and a 52-week high of $17.40, providing a clear range within which price discovery occurs. The beta value is 0.92, which indicates that the stock's price volatility moves in line with the broader market, exhibiting slightly lower sensitivity to market fluctuations than a beta of 1.0 would suggest.
Growth & Income
Revenue growth year-over-year declined by 31.6%, while earnings growth year-over-year contracted even more sharply at -82.1%, indicating that earnings are shrinking at a much faster rate than revenue, likely due to the impact of higher interest rates on fixed-income portfolios or increased claim costs. The company offers a dividend yield of 10.3%, which is exceptionally high, but the payout ratio is not available; however, the massive negative free cash flow and significant contraction in earnings suggest that sustaining this high dividend payout is challenging without significant capital support or changes in the investment environment. The company does not disclose a payout ratio, which, in the context of negative free cash flow and declining earnings, implies that the dividend may be funded by cash reserves or asset sales rather than organic earnings generation. Overall, the growth and income profile presents a complex picture of a mature insurer delivering high current income potential through dividends while simultaneously experiencing significant headwinds in both revenue stability and earnings growth, requiring careful analysis of the underlying asset quality to determine long-term sustainability.